Not much to show for $1.9 billion: New directions in mental health needed

+Practice
In print
CLINICAL COMMENT

Not much to show for $1.9 billion: New directions in mental health needed

By William Ferguson
Stormy skies
As you search for the blue skies, do not lose track of the principles of providing good care [Image: Raychel Sanner on Unsplash]

This article highlights new ways of understanding mental illness and explores new treatment strategies, including the use of nutrients in carefully targeted patient groups

Key points, There is significant disconnect between the current paradigm of mental illness and the new insights being gained from genome-wide association studies , Pract Green w Pale Yellow
References

1. He Ara Oranga: Report of the Government Inquiry into Mental Health and Addiction. Government Inquiry into Mental Health and Addiction; November 2018. https://www.mentalhealth.inquiry.govt.nz/inquiry-report/

2. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007;9(6):449–59.

3. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013;18(4):497–511.

4. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013;45(9):984–94.

5. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015;18(2):199–209.

6. Theunissen G, D’Souza S, Peterson ER, et al. Prenatal determinants of depressive symptoms in childhood: Evidence from Growing Up in New Zealand. J Affect Disord 2022;302:41–49.

7. Gottesman II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 2003;160:636–45.

8. Sarris J, Murphy J, Mischoulon D, et al. Adjunctive nutraceuticals for depression: A systematic review and meta-analyses. Am J Psychiatry 2016;173(6):575–87.

9. Galizia I, Oldani L, Macritchie K, et al. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database Syst Rev 2016;10(10):CD011286.

10. Jacka F, Berk M. Food for thought. Acta Neuropsychiatrica 2007;19(5):321–23.

11. Freeman MP. Nutrition and psychiatry. Am J Psychiatry 2010;167(3):244–47.

12. Sarris J, Logan AC, Akbaraly TN, et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry 2015;2(3):271–74.

13. McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 2008;1237:12–24.

14. Thase ME. An Update on the Neurobiological Understanding of Depression. 2012. www.medscape.org